Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Pfizer
NeoImmuneTech
Alterome Therapeutics, Inc.
ToLymph Inc.
Hoffmann-La Roche
Nuvectis Pharma, Inc.
AstraZeneca
Istituto Oncologico Veneto IRCCS
AstraZeneca
Avenzo Therapeutics, Inc.
Boehringer Ingelheim
Shanghai Pulmonary Hospital, Shanghai, China
AstraZeneca
Pheon Therapeutics
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.
Pfizer
Revolution Medicines, Inc.
Nuvation Bio Inc.
Inhibrx Biosciences, Inc
Tanabe Pharma America, Inc.
Adaptimmune
Novartis
CRISPR Therapeutics
AstraZeneca
TScan Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Massive Bio, Inc.
AstraZeneca
AstraZeneca
Sichuan Baili Pharmaceutical Co., Ltd.
Genelux Corporation
Travera Inc
Institut Bergonié
Sanofi
Trans Tasman Radiation Oncology Group
University Health Network, Toronto
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
AstraZeneca
Hoffmann-La Roche
Numab Therapeutics AG
Centre Antoine Lacassagne
Creative Biosciences (Guangzhou) Co., Ltd.